IAM
Iridian Asset Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.22M | Sell |
47,566
-12,853
| -21% | -$1.95M | 2.5% | 13 |
|
|
2025
Q1 | $9.09M | Buy |
60,419
+9,454
| +19% | +$1.42M | 2.85% | 12 |
|
|
2024
Q4 | $9.41M | Sell |
50,965
-4,078
| -7% | -$753K | 2.5% | 14 |
|
|
2024
Q3 | $10.8M | Buy |
55,043
+8,876
| +19% | +$1.75M | 2.32% | 17 |
|
|
2024
Q2 | $9.54M | Buy |
46,167
+21,763
| +89% | +$4.5M | 2.15% | 17 |
|
|
2024
Q1 | $6.61M | Sell |
24,404
-6,738
| -22% | -$1.83M | 1.3% | 19 |
|
|
2023
Q4 | $7.36M | Buy |
31,142
+1,803
| +6% | +$426K | 1.34% | 15 |
|
|
2023
Q3 | $5.75M | Sell |
29,339
-38,039
| -56% | -$7.45M | 1.16% | 22 |
|
|
2023
Q2 | $14.2M | Buy |
67,378
+1,309
| +2% | +$275K | 1.32% | 22 |
|
|
2023
Q1 | $13.3M | Sell |
66,069
-12,607
| -16% | -$2.54M | 1.09% | 24 |
|
|
2022
Q4 | $17.1M | Sell |
78,676
-9,288
| -11% | -$2.02M | 1.65% | 21 |
|
|
2022
Q3 | $17.3M | Sell |
87,964
-4,771
| -5% | -$939K | 1.72% | 24 |
|
|
2022
Q2 | $19.8M | Buy |
92,735
+18,245
| +24% | +$3.9M | 1.62% | 25 |
|
|
2022
Q1 | $21.2M | Buy |
74,490
+15,974
| +27% | +$4.54M | 1.47% | 26 |
|
|
2021
Q4 | $22M | Sell |
58,516
-52,277
| -47% | -$19.7M | 1.35% | 34 |
|
|
2021
Q3 | $45.7M | Sell |
110,793
-95,394
| -46% | -$39.4M | 1.4% | 33 |
|
|
2021
Q2 | $76.3M | Sell |
206,187
-34,754
| -14% | -$12.9M | 1.33% | 39 |
|
|
2021
Q1 | $69.8M | Sell |
240,941
-39,566
| -14% | -$11.5M | 1.19% | 37 |
|
|
2020
Q4 | $70.1M | Sell |
280,507
-42,648
| -13% | -$10.7M | 1.28% | 35 |
|
|
2020
Q3 | $73.2M | Sell |
323,155
-113,625
| -26% | -$25.7M | 1.6% | 32 |
|
|
2020
Q2 | $76.2M | Sell |
436,780
-40,377
| -8% | -$7.04M | 1.68% | 30 |
|
|
2020
Q1 | $60.2M | Buy |
477,157
+266,270
| +126% | +$33.6M | 1.46% | 30 |
|
|
2019
Q4 | $32.2M | Buy |
+210,887
| New | +$32.2M | 0.53% | 46 |
|